Corey Falcon
Pediatric Hematology-Oncology · Metairie, LANPI 1295902989
Payments from drug & device makers
What this record shows
The money is spread across several categories — speaking fees (41.9%), consulting fees and travel and lodging — rather than concentrated in one kind of arrangement. 28 manufacturers reported payments, led by Sobi, Inc at 30.0% of the total. Among pediatric hematology-oncology clinicians in LA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 209 payments — averaging $496.02 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Sobi, Inc$31K
- Sanofi$21K
- Global Blood Therapeutics, Inc.$19K
- Octapharma USA, Inc.$12K
- Sanofi US Services Inc.$10K
- Pfizer$8K
- plus $2K from 22 others
Across 10 payments — averaging $5872.64 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- AstraZeneca$44K
- Merck$14K
What the payments were for
- Consulting fees$38,20937%
- Speaking & faculty fees$43,48042%
- Travel & lodging$15,26715%
- Food & beverage$6,4926%
- Education$2210%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Sobi, Inc | 49 | $31,067 |
| Sanofi | 22 | $21,120 |
| Global Blood Therapeutics, Inc. | 35 | $19,418 |
| Octapharma USA, Inc. | 35 | $12,083 |
| Sanofi US Services Inc. | 1 | $10,385 |
| Pfizer | 15 | $7,572 |
| Genetix Biotherapeutics Inc | 3 | $314 |
| Amgen | 6 | $295 |
| Novo Nordisk | 6 | $246 |
| Tempus AI, Inc | 2 | $210 |
| Y-mabs Therapeutics, Inc. | 3 | $170 |
| Dova Pharmaceuticals | 1 | $131 |
| Genentech USA, Inc. | 3 | $91 |
| AstraZeneca | 4 | $90 |
| Springworks Therapeutics, Inc. | 4 | $90 |
| Novartis | 3 | $58 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $52 |
| Servier Pharmaceuticals LLC | 2 | $39 |
| Seagen Inc. | 2 | $38 |
| Day One Biopharmaceuticals | 2 | $38 |
| HEMA Biologics, LLC | 2 | $34 |
| USWM, LLC | 1 | $28 |
| Bayer | 1 | $19 |
| UCB, Inc. | 1 | $18 |
| Agios Pharmaceuticals, Inc. | 1 | $17 |
| Syndax Pharmaceuticals, Inc. | 1 | $16 |
| BTG International Inc. | 1 | $16 |
| Bristol Myers Squibb | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Gamifant$23,708
- OXBRYTA$22,893
- ALTUVIIIO$19,913
- DOPTELET$6,935
- WILATE - VON WILLEBRAND FACTOR/COAGULATION FACTOR VIII COMPLEX (HUMAN)$4,149
- NUWIQ$4,130
- FIBRYGA & BALFAXAR$3,308
- QFITLIA$1,441
- Blincyto$122
- DANYELZA$110
How this compares
$103,669 in reported general payments places this provider in the 90th percentile of 26 pediatric hematology-oncology providers in Louisiana.
See all pediatric hematology-oncology providers in Louisiana →
Other pediatric hematology-oncology in Metairie
- Maria Espanol MendezMetairie$7K
- Tammuella Chrisentery-SingletonNew Orleans$1.4M
- Maria Velez-YanguasNew Orleans$105K
- Zachary LeblancNew Orleans$55K
- Dana LeblancNew Orleans$25K
- Renee GardnerNew Orleans$25K
- Pinki PrasadNew Orleans$20K
- Robert VasquezNew Orleans$6K
- Lolie YuNew Orleans$3K
- Craig LottermanNew Orleans$3K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.